Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-04 Sale | 2025-02-06 8:27 pm | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 3,770 | $21.38 | $80,615 | 57,235 (Direct) | View |
| 2025-02-04 Sale | 2025-02-06 8:27 pm | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 3,921 | $21.38 | $83,836 | 51,704 (Direct) | View |
| 2025-02-04 Sale | 2025-02-06 8:27 pm | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 9,352 | $21.39 | $200,075 | 239,454 (Direct) | View |
| 2025-02-04 Sale | 2025-02-06 8:26 pm | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 2,787 | $21.4 | $59,653 | 38,830 (Direct) | View |
| 2024-02-02 Sale | 2024-02-06 8:18 pm | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 14,519 | $1.1361 | $16,496 | 349,093 (Direct) | View |
| 2024-02-02 Sale | 2024-02-06 8:18 pm | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 12,628 | $1.1354 | $14,338 | 402,891 (Direct) | View |
| 2024-02-02 Sale | 2024-02-06 8:18 pm | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 52,894 | $1.1359 | $60,082 | 2,036,629 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-29 Option Award | 2025-01-31 6:47 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer | 34,505 | $0 | 34,505 (Direct) | View |
| 2025-01-29 Option Award | 2025-01-31 6:47 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 105,700 | $0 | 312,206 (Direct) | View |
| 2025-01-29 Option Award | 2025-01-31 6:47 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 34,505 | $0 | 75,793 (Direct) | View |
| 2025-01-29 Option Award | 2025-01-31 6:47 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 34,505 | $0 | 70,413 (Direct) | View |
| 2025-01-29 Option Award | 2025-01-31 6:45 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 34,505 | $0 | 56,405 (Direct) | View |
| 2025-01-24 Tax Withholding | 2025-01-28 8:49 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 44,078 | $22.17 | 206,506 (Direct) | View |
| 2025-01-24 Exercise | 2025-01-28 8:49 pm | N/A 2025-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 90,000 | $0 | 206,506 (Direct) | View |
| 2025-01-24 Exercise | 2025-01-28 8:49 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 45,000 | $21.4 | 206,506 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-26 8:01 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 8,000 | $0 | 8,000 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-26 8:01 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-26 8:01 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 6,250 | $0 | 6,250 (Direct) | View |
| 2024-08-30 Option Award | 2024-09-04 8:36 pm | N/A 2030-02-06 | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 32,500 | $0 | 32,500 (Direct) | View |
| 2024-08-30 Option Award | 2024-09-04 8:33 pm | N/A 2030-02-06 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-25 Option Award | 2024-05-29 7:21 pm | N/A 2034-05-25 | RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director | 55,000 | $0 | 130,000 (Direct) | View |
| 2024-05-25 Option Award | 2024-05-29 7:21 pm | N/A 2034-05-25 | RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director | 55,000 | $0 | 132,222 (Direct) | View |
| 2024-05-25 Option Award | 2024-05-29 7:20 pm | N/A 2034-05-25 | RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director | 55,000 | $0 | 130,000 (Direct) | View |
| 2024-05-25 Option Award | 2024-05-29 7:20 pm | N/A 2034-05-25 | RIGEL PHARMACEUTICALS INC | RIGL | Kotzin Brian L. Director | 55,000 | $0 | 130,000 (Direct) | View |
| 2024-05-25 Option Award | 2024-05-29 7:20 pm | N/A 2034-05-25 | RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director | 55,000 | $0 | 111,250 (Direct) | View |
| 2024-05-25 Option Award | 2024-05-29 7:19 pm | N/A 2034-05-25 | RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director | 55,000 | $0 | 98,750 (Direct) | View |
| 2024-03-27 Option Award | 2024-03-29 4:09 pm | N/A 2034-03-27 | RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer | 187,500 | $0 | 187,500 (Direct) | View |
| 2024-02-28 Option Award | 2024-03-01 7:16 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 141,000 | $0 | 141,000 (Direct) | View |
| 2024-02-28 Option Award | 2024-03-01 7:15 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 158,500 | $0 | 158,500 (Direct) | View |
| 2024-02-28 Option Award | 2024-03-01 7:15 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 600,000 | $0 | 600,000 (Direct) | View |
| 2024-02-28 Option Award | 2024-03-01 7:14 pm | N/A 2032-12-08 | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 172,250 | $0 | 172,250 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 9:17 pm | N/A 2034-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 366,000 | $0 | 371,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 9:17 pm | N/A 2034-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 1,000,000 | $0 | 2,689,523 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 9:17 pm | N/A 2034-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 366,000 | $0 | 520,612 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 9:16 pm | N/A 2034-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 366,000 | $0 | 572,519 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director | 55,000 | $0 | 105,000 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director | 55,000 | $0 | 107,222 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director | 55,000 | $0 | 105,000 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | LYONS GARY A Director | 55,000 | $0 | 105,000 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director | 55,000 | $0 | 73,750 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | Kotzin Brian L. Director | 55,000 | $0 | 105,000 (Direct) | View |